Loading...

Deputy Chair Meghan Leigh shares updates from the Study Coordinator Committee Workshop

Meghan Leigh, Deputy Chair of the Study Coordinator Committee, shares updates from the Study Coordinator Committee's latest workshop on the National Clinical Trials Governance Framework. Meghan Leigh is the Deputy Chair of the Study Coordinator [...]

Deputy Chair Meghan Leigh shares updates from the Study Coordinator Committee Workshop2021-02-10T04:24:04+11:00

TR-ANZGOG launches – ANZGOG’s exciting translational research initiative

Translational ANZGOG, ‘TR-ANZGOG’, is an exciting ANZGOG research initiative established to achieve a 2015 ANZGOG Strategic Goal: “World-class translational research in gynaecological cancers”. TR-ANZGOG Steering Committee Chair, Professor Anna DeFazio and TR-ANZGOG Project Manager, Claire [...]

TR-ANZGOG launches – ANZGOG’s exciting translational research initiative2021-02-10T04:24:10+11:00

Assoc Prof Yoland Antill shares updates from the Uterine Tumour Type Working Group

Assoc Prof Yoland Antill, Chair of ANZGOG's Uterine Tumour Type Working Group, shares updates from the group's recent meeting on protocol developments in existing research studies and upcoming trials for endometrial cancer patients. [...]

Assoc Prof Yoland Antill shares updates from the Uterine Tumour Type Working Group2021-02-10T04:30:54+11:00

Prof Madeleine King explains the pioneering MOST tool and how it developed in ANZGOG’s Symptom Benefit study

Professor Madeleine King, a former member of ANZGOG’s Research Advisory Committee and a key collaborator on one of ANZGOG’s most important studies – Symptom Benefit - to speak about the development of the MOST instrument in the [...]

Prof Madeleine King explains the pioneering MOST tool and how it developed in ANZGOG’s Symptom Benefit study2024-03-01T11:05:51+11:00

Consumer Research Panelist and cancer survivor Lisa Finucane celebrates her ten-year survival milestone

Celebrating her ten-year survival milestone during #GynaecologicalCancerAwarenessMonth, Consumer Research Panelist, Lisa Finucane, advocates for ovarian cancer awareness and pioneering research to hopefully one day find a cure. Lisa was diagnosed with Stage 3 Low [...]

Consumer Research Panelist and cancer survivor Lisa Finucane celebrates her ten-year survival milestone2021-02-10T04:25:19+11:00
Go to Top